Skip to search formSkip to main contentSkip to account menu

FI-700

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Fms-like tyrosine kinase-3 (FLT3) inhibitors have been used to overcome the dismal prognosis of acute myeloid leukemia (AML) with… 
2011
2011
Internal tandem duplication of FMS‐like receptor tyrosine kinase 3 (FLT3/ITD) within its juxtamembrane domain is a frequent… 
2010
2010
Treatment using Fms-like tyrosine kinase-3 (FLT3) inhibitors is a promising approach to overcome the dismal prognosis of acute… 
2009
2009
Abstract 3108 Poster Board III-45 Background FLT3 (FMS-like receptor tyrosine kinase 3) is a member of the class III receptor… 
2007
2007
Purpose: The aim of this study was to evaluate the antileukemia activity of a novel FLT3 kinase inhibitor, FI-700. Experimental…